| Literature DB >> 28363407 |
Brahma N Singh1, Dalip K Upreti2, Vijai K Gupta3, Xiao-Feng Dai4, Yueming Jiang5.
Abstract
Endolichenic fungi (ELF) offer an opportunity to discover emerging natural drugs. ELF are promising bioresources given their ability to produce bioactive metabolites that represent unique and diverse structural classes. Here, we assess the potential of recent technologies to provide insight into the chemical diversity of ELF for biopharmaceutical development.Mesh:
Year: 2017 PMID: 28363407 DOI: 10.1016/j.tibtech.2017.03.003
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536